Adhera Therapeutics Inc (ATRX)

[rodster73]

BOTHELL, WA, Mar 08, 2010 (MARKETWIRE via COMTEX) -- MDRNA, Inc. (NASDAQ:
MRNA), a leading RNAi-based drug discovery and development company, today
announced that J. Michael French, MDRNA's President and Chief Executive Officer,
will provide an overview of the Company and its progress in key programs at the
following upcoming conferences:





-- The ROTH 22nd Annual OC Growth Stock Conference, on Monday, March 15 at

4:30 p.m. Pacific Time at the Ritz-Carlton in Dana Point, California;

and

-- The Washington Biotechnology & Biomedical Association (WBBA) 10th Annual

"Life Science Innovation Northwest" Conference on Wednesday, March 17 at

1:55 p.m. Pacific Time at the Bell Harbor International Conference

Center in Seattle, Washington.



A live audio webcast of each presentation will be available on the Event
Calendar page of the Investors section of the Company's website at
http://www.mdrnainc.com. Please allow time prior to the presentation to register
and download any necessary software. A replay of the presentation will be
available on the Investors section of the MDRNA website under Event Calendar
approximately one hour after the live presentation and will be archived for
three months.